Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24

Nature. 1991 Jan 10;349(6305):161-4. doi: 10.1038/349161a0.

Abstract

Familial combined hyperlipidaemia (FCHL) is a common inherited disorder of lipid metabolism with a prevalence of 0.5-2.0% (refs 1, 2). It is estimated to cause 10% of premature coronary heart disease. The underlying metabolic and genetic defects in FCHL have not been identified, but a population study has suggested an association between FCHL and an XmnI restriction fragment length polymorphism (RFLP) within the apolipoprotein AI-CIII-AIV gene cluster. Here we confirm this association and show that it results from linkage disequilibrium between FCHL and the 6.6-kilobase (kb) allele of the XmnI RFLP. Subsequent analysis in seven FCHL families, ascertained through a proband carrying the 6.6 kb XmnI allele, demonstrated linkage to the AI-CIII-AIV cluster on 11q23-q24, zeta = 6.86 with no recombinants. This assignment will facilitate the identification of the mutation that causes hyperlipidaemia in these families.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoprotein A-I
  • Apolipoprotein C-III
  • Apolipoproteins A / genetics*
  • Apolipoproteins C / genetics*
  • Chromosomes, Human, Pair 11*
  • Gene Frequency
  • Genetic Linkage
  • Humans
  • Hyperlipidemia, Familial Combined / genetics*
  • Oligonucleotide Probes
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length

Substances

  • Apolipoprotein A-I
  • Apolipoprotein C-III
  • Apolipoproteins A
  • Apolipoproteins C
  • Oligonucleotide Probes
  • apolipoprotein A-IV